2nd COVID-19 vaccine set for OK in US with panel endorsement

Virus Outbreak
FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one of the most pressing questions in the U.S. coronavirus epidemic: When the first doses of COVID-19 vaccine become available, who should be at the front of the line for shots? (AP Photo/Hans Pennink, File)

WASHINGTON (AP) — A  U.S. government advisory panel has endorsed a second COVID-19 vaccine.

The action Thursday paves the way for the shot from Moderna to be added to the U.S. vaccination campaign.

The Food and Drug Administration is expected to act quickly to authorize the vaccine for emergency use. The vaccination effort kicked off this week with a vaccine from Pfizer.

A second vaccine is urgently needed as coronavirus infections, hospitalizations and deaths in the U.S. climb to new highs ahead of the holidays.

Doses for now are being earmarked for health care workers and nursing home residents.

Categories: Coronavirus, National News